"Health & Medical News"

Washington — As research findings coalesce around a collection of risk factors for Alzheimer’s disease, it is becoming obvious that poor and minority populations — the ones most likely to harbor risk factors such as hypertension and diabetes –also are more likely than whites to encounter this brain disorder.

Read the rest of this entry »

Popularity: unranked [?]

Washington — Dementia in people younger than 65 isn’t always the result of early-onset Alzheimer’s disease. Frontotemporal lobar degeneration, or FTLD, an umbrella term that covers several brain disorders, is another cause of early dementia, although one that is not widely recognized.

The announcement last fall by Sen. Pete Domenici (R, N.M) that he has FTLD placed a spotlight on the condition, at least momentarily. However, FTLD remains very much in the shadow of Alzheimer’s.

Read the rest of this entry »

Popularity: unranked [?]

An anti-psychotic drug already approved in the U.S. to treat adults and adolescents with schizophrenia may soon be available for youngsters age 10 to 17 years of age suffering from bipolar disorder.

The U.S. Food and Drug Administration (FDA) has given priority review status to the drug Abilify which is manufactured by Bristol-Myers Squibb and Otsuka Pharmaceutical.

Read the rest of this entry »

Popularity: unranked [?]